ADT and cardiac risks (and how I sold my company for $1.4bn)
Ғылым және технология
Professor Neil Fleshner (University of Toronto) drops into the GU Cast studio in Melbourne for an intriguing discussion! First we cover off the underrated topic of cardiac risks in patients starting androgen deprivation therapy and how we can reduce these for the benefit of our patients. Then we talk to Neil about entrepreneurship and his journey into very successful business ventures in recent years. He has some inspiring stories and some great advice for frustrated clinicians out there!
This episode is a Themed Podcast supported by our Bronze Partners, Cipla Australia.
Also available as a classic audio podcast in all the usual places
Пікірлер: 4
Great episode - inspirational in the second half discussing surgical entrepreneurship. Now to go bother co-conspirators with my ideas!
@gu_cast
15 күн бұрын
Yep very inspirational listening to Neil! He is very modest
Regarding Dr. Flesher's lutetium PSMA-Germany story, I find it interesting that Dr. Hofman did a sabbatical with Dr. Richard Baum at Zentralkinik Bad Berka in 2016. Seems like we have Germany and doctors like Richard Baum to thank for the spread of PSMA RLT throughout the world.
@gu_cast
Күн бұрын
That's for sure! Michael always gives Dr Baum a lot of credit, and indeed many other excellent doctors/nuc med technicians/physicians/nurses working in German centres who have done so much to advance the fields of PSMA imaging and theranostics. Declan and Renu